Thierry Kalonji

Dr. Thierry Kalonji

National Mpox and Viral haemorrhagic Fever control program, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Emerging Infectious Diseases
Verified
Journal Article
Open access
EKEmile M. Kibungu
Emile M. Kibungu
EVEmmanuel H. Vakaniaki
Emmanuel H. Vakaniaki
EKEddy Kinganda-Lusamaki
Eddy Kinganda-Lusamaki
TKThierry Kalonji
Thierry Kalonji
EPElisabeth Pukuta
Elisabeth Pukuta
RLRobert S. Lushima
Robert S. Lushima
Clade I Mpox, Democratic Republic of the Congo

30 January 2025 in The Lancet
Verified
Journal Article
Closed access
EBEugene Bangwen
Eugene Bangwen
RDRuth Diavita
Ruth Diavita
EVElise De Vos
Elise De Vos
EVEmmanuel Hasivirwe Vakaniaki
Emmanuel Hasivirwe Vakaniaki
SNSabin Sabiti Nundu
Sabin Sabiti Nundu
PMPlacide Mbala-Kingebeni
Placide Mbala-Kingebeni

7 July 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
ELEddy Kinganda - Lusamaki
Eddy Kinganda - Lusamaki
LBLionel Kinzonzi Baketana
Lionel Kinzonzi Baketana
ENEtienne Mukanya Ndomba
Etienne Mukanya Ndomba
JBJulie Bouillin
Julie Bouillin
GTGuillaume Thaurignac
Guillaume Thaurignac
SMSteve Ahuka Mundeke
Steve Ahuka Mundeke
Human Mpox cases are increasingly reported in Africa, with the highest burden in the Democratic Republic of Congo (DRC). While case reporting on a clinical basis can overestimate infection rates, laboratory confirmation by PCR can underestimate them, especially on suboptimal samples like blood, commonly used in DRC. Here we used a Luminex-based assay to evaluate whether antibody testing can be complementary to confirm cases and to identify human transmission chains during outbreak investigations. We used left-over blood samples from 463 patients, collected during 174 outbreaks between 2013 and 2022, with corresponding Mpox and VZV PCR results. In total, 157 (33.9%) samples were orthopox-PCR positive and classified as Mpox+; 124 (26.8%) had antibodies to at least one of the three Mpox peptides. The proportion of antibody positive samples was significantly higher in Mpox positive samples (36.9%) versus negative (21.6%) (p < 0.001). By combining PCR and serology, 66 additional patients were identified, leading to an Mpox infection rate of 48.2% (223/463) versus 33.9% when only PCR positivity is considered. Mpox infections were as such identified in 14 additional health zones and 23 additional outbreaks (111/174 (63.8%) versus 88/174 (50.6%)). Our findings highlight the urgent need of rapid on-site diagnostics to circumvent Mpox spread.

10 February 2025 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
Ananda TiwariAnanda Tiwari
Ananda Tiwari
TKThierry Kalonji
Thierry Kalonji
TMTaru Miller
Taru Miller
TBTim Van Den Bossche
Tim Van Den Bossche
AKAdriana Krolicka
Adriana Krolicka
VTVivi Maketa Tevuzula
Vivi Maketa Tevuzula
Several African countries, mainly the Democratic Republic of Congo, Burundi, and Uganda, are facing highly transmissible mpox clade Ib epidemics, prompting the World Health Organization to declare a Public Health Emergency of International Concern. It has spread to key travel hubs like Kinshasa, Bujumbura, and Kampala, increasing international spread risks. Current mitigation efforts focus mainly on medical care, diagnostics, vaccination, and infection prevention, but overlook wastewater and environmental surveillance (WES). WES can be effective in detecting hotspots and enabling rapid response through enhanced data collection and genomic sequencing. This perspective article reviews the latest outbreak situation and advocates integrating WES into response strategies.

1 October 2024 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
EVEmmanuel Hasivirwe Vakaniaki
Emmanuel Hasivirwe Vakaniaki
EKEddy Kinganda-Lusamaki
Eddy Kinganda-Lusamaki
SMSydney Merritt
Sydney Merritt
FKFrancois Kasongo
Francois Kasongo
EMEmile Malembi
Emile Malembi
PMPlacide Kingebeni Mbala
Placide Kingebeni Mbala
Transmission of Distinct Monkeypox Virus Variants

1 April 2024 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
TKThierry Kalonji
Thierry Kalonji
EMEmile Malembi
Emile Malembi
JMJean Paul Matela
Jean Paul Matela
TLToutou Likafi
Toutou Likafi
EKEddy Kinganda-Lusamaki
Eddy Kinganda-Lusamaki
PMPlacide Mbala-Kingebeni
Placide Mbala-Kingebeni
Co-Circulating Monkeypox and Swinepox Viruses